Well Referenced

Tag: gastrointestinal cancer

The Association Between Urinary Cadmium Levels and Dietary Habits with Risk of Gastrointestinal Cancer in Tabriz, Northwest of Iran

This case-control study investigated the relationship between urinary cadmium (U-Cd) levels, dietary habits, and the risk of gastrointestinal (GI) cancer among 111 patients with GI cancer and 111 healthy controls in Tabriz, Iran. Urinary cadmium concentrations were measured using graphite furnace atomic absorption spectrophotometry. The study found that GI cancer

Read More »
June 26, 2025 No Comments

Melatonin as a treatment for gastrointestinal cancer: a review

This 2015 review examines melatonin’s potential as a therapeutic agent against gastrointestinal (GI) cancers. It highlights the association between disrupted melatonin rhythms and increased GI cancer risk, as evidenced by epidemiological and experimental studies. Melatonin’s anticancer mechanisms include inhibition of cell proliferation, invasion, metastasis, and angiogenesis, as well as promotion

Read More »
June 26, 2025 No Comments

Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy

This cohort study of 103 patients with gastrointestinal cancers undergoing concurrent chemoradiation therapy (CXRT) found that elevated levels of inflammatory markers—soluble tumor necrosis factor receptor 1 (sTNF-R1) and interleukin-6 (IL-6)—were significantly associated with worsening fatigue and other symptoms such as pain, drowsiness, and poor appetite during treatment. Both markers increased

Read More »
June 26, 2025 No Comments